Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Synthesis and structural characterization of rhenium(I) tricarbonyl complexes with the bidentate ligands o-(diphenylphosphino)benzaldehyde (P∩O) and o-[(diphenylphosphino)benzylidene]analine (P∩N).

Literature DB >> 21603092

Synthesis and structural characterization of rhenium(I) tricarbonyl complexes with the bidentate ligands o-(diphenylphosphino)benzaldehyde (P∩O) and o-[(diphenylphosphino)benzylidene]analine (P∩N).

Xiaoyuan Chen¹, Frank J Femia, John W Babich, Jon Zubieta.

Abstract

A series of rhenium(I) tricarbonyl complexes with bidentate P,O donor ligand o-(diphenylphosphino)benzaldehyde (P∩O) and its Schiff base P,N donor ligand o-[diphenylphosphino)benzylidene]analine (P∩N) have been synthesized and structurally characterized. All the complexes of the type [ReX(CO)(3)(LL)] (where LL = P∩O, P∩N) reveal a distorted octahedral structure with the three carbonyl ligands arranged in the facial fashion. Crystal data for 1, C(22)H(15)ClO(4)PRe·1/2C(6)H(14): triclinic, P1, a=8.7430(4), b=9.5767(4), c=13.9449(6) Å, α=93.651(1), β=101.265(1), γ=93.048(1); V=1140.20(9) Å(3), Z=2.2, C(22)H(15)BrO(4)Pre: monoclinic, C2/c, a=31.6800(16), b=8.8880(4), c=18.4517(9) Å, β=124.990(1); V=4256.4(4) Å(3), Z=8. 3, C(28)H(20)ClNO(3)Pre: monoclinic, C2/c, a=22.675(4), b=8.803(2), c=28.218(5) Å, β=100.192(3); V=5543.5(16) Å(3), Z=8.4, C(28)H(20)BrNO(3)Pre: monoclinic, C2/c, a=23.035(1), b=8.7561(4), c=28.269(1) Å, β=100.811(1); V=5600.4(5) Å(3), Z=8.

Entities: Chemical Disease Species

Year: 2001 PMID： 21603092 PMCID： PMC3098572 DOI： 10.1016/S0020-1693(01)00302-4

Source DB: PubMed Journal: Inorganica Chim Acta ISSN： 0020-1693 Impact factor: 2.545

12 in total

1. Therapeutic radiopharmaceuticals.

Authors: W A Volkert; T J Hoffman
Journal: Chem Rev Date: 1999-09-08 Impact factor: 60.622

2. Potential technetium small molecule radiopharmaceuticals.

Authors: S S Jurisson; J D Lydon
Journal: Chem Rev Date: 1999-09-08 Impact factor: 60.622

3. 99mTc-Labeled Small Peptides as Diagnostic Radiopharmaceuticals.

Authors: S Liu; D S Edwards
Journal: Chem Rev Date: 1999-09-08 Impact factor: 60.622

4. Oxorhenium(V) complexes containing tridentate Schiff-base and monothiol coligands.

Authors: Frank J Femia; Xiaoyuan Chen; John W Babich; Jon Zubieta
Journal: Inorganica Chim Acta Date: 2000-04-20 Impact factor: 2.545

5. Influence of the denticity of ligand systems on the in vitro and in vivo behavior of (99m)Tc(I)-tricarbonyl complexes: a hint for the future functionalization of biomolecules.

Authors: R Schibli; R La Bella; R Alberto; E Garcia-Garayoa; K Ortner; U Abram; P A Schubiger
Journal: Bioconjug Chem Date: 2000 May-Jun Impact factor: 4.774

6. Exploring oxorhenium '3+1' mixed-ligand complexes carrying the S-benzyl-3-[(2-hydroxyphenyl)methylene]dithiocarbazate [ONS]/monothiol [S] donor set: synthesis and characterization.

Authors: Xiaoyuan Chen; Frank J Femia; John W Babich; Jon Zubieta
Journal: Inorganica Chim Acta Date: 2000-09-11 Impact factor: 2.545

7. Synthesis and crystal and molecular structure of a tetranuclear cluster based on the rhenium(III)-bisorganohydrazino core: [Re(HNNC(4)H(3)N(2))(NNC(4)H(3)N(2))(OCH(3))(2)](4).

Authors: Frank J Femia; Xiaoyuan Chen; Kevin P Maresca; John W Babich; Jon Zubieta
Journal: Inorganica Chim Acta Date: 2000-09-01 Impact factor: 2.545

8. Schiff base chemistry of the {ReO} core: structural characterization of the unusual '3 + 2' complex [ReO(eta-OC(6)H(4)-CH=NC(6)H(4)-2-S)(eta-OC(6)H(4))].

Authors: Xiaoyuan Chen; Frank J Femia; John W Babich; Jon Zubieta
Journal: Inorganica Chim Acta Date: 2000-09-11 Impact factor: 2.545

Synthesis and structural characterization of rhenium(I) tricarbonyl complexes with the bidentate ligands o-(diphenylphosphino)benzaldehyde (P∩O) and o-[(diphenylphosphino)benzylidene]analine (P∩N).

1. Therapeutic radiopharmaceuticals.

2. Potential technetium small molecule radiopharmaceuticals.

3. 99mTc-Labeled Small Peptides as Diagnostic Radiopharmaceuticals.

4. Oxorhenium(V) complexes containing tridentate Schiff-base and monothiol coligands.

5. Influence of the denticity of ligand systems on the in vitro and in vivo behavior of (99m)Tc(I)-tricarbonyl complexes: a hint for the future functionalization of biomolecules.

6. Exploring oxorhenium '3+1' mixed-ligand complexes carrying the S-benzyl-3-[(2-hydroxyphenyl)methylene]dithiocarbazate [ONS]/monothiol [S] donor set: synthesis and characterization.

7. Synthesis and crystal and molecular structure of a tetranuclear cluster based on the rhenium(III)-bisorganohydrazino core: [Re(HNNC(4)H(3)N(2))(NNC(4)H(3)N(2))(OCH(3))(2)](4).

8. Schiff base chemistry of the {ReO} core: structural characterization of the unusual '3 + 2' complex [ReO(eta-OC(6)H(4)-CH=NC(6)H(4)-2-S)(eta-OC(6)H(4))].

9. Neutral and stereospecific Tc-99m complexes: [99mTc]N-benzyl-3,4-di-(N-2-mercaptoethyl)-amino-pyrrolidines (P-BAT).

10. Stability versus reactivity of "3+1" mixed-ligand technetium-99m complexes in vitro and in vivo.

1. Tricarbonyl-chlorido{N-[2-(diphenyl-phosphino)benzyl-idene]benzyl-amine-κN,P}rhenium(I) dichloro-methane solvate.

2. fac-Bromidotricarbonyl[2-(diisopropylphosphanyl)benzaldehyde-κ(2)O,P]rhenium(I).

3. Technetium-99m Tricarbonyl Labeled a Broad-spectrum Quinolone as a Specific Imaging Agent in Infection Diseases.